1-3 of 3
Jung-Sun Kim
Close
Sort by
Journal Articles

Exploration of the Appropriate NT-Probnp Level for AL Amyloidosis Staging

Hana Kim, Darae Kim, Jinoh Choi, Eunseok Jeon, Jung Eun Lee, Ju Hong Min, Joon Young Choi, Jung-Sun Kim, Seokjin Kim, Kihyun Kim
Journal: Blood
Blood (2021) 138 (Supplement 1): 3777.
https://doi.org/10.1182/blood-2021-151675
Published: 2021
Journal Articles

Bortezomib-Based First Line Treatment for AL Amyloidosis Patients Who Are Not Candidate for Stem Cell Transplantaion

Joon Young Hur, MD, Kang Kook Lee, MD, Sang Eun Yoon, MD, Sehhoon Park, MD, Jangho Cho, MD, Youjin Kim, MD, Eunseok Jeon, MD PhD, Jinoh Choi, MD PhD, Gayeon Lee, MD PhD, Byungjun Kim, MD PhD, Ju Hong Min, MD PhD, Jung Sun Kim, MD PhD, Jung Eun Lee, MD PhD, Joon Young Choi, MD PhD, Seok Jin Kim, MD PhD, Jun Ho Jang, MD PhD, Won-Seog Kim, MD PhD, Chul Won Jung, MD PhD, Kihyun Kim, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3256.
https://doi.org/10.1182/blood-2018-99-114099
Published: 2018
Journal Articles

Efficacy of Bortezomib-Based Regimens for Patients with Newly Diagnosed AL Amyloidosis Not Receiving ASCT Compared with Alkylators and Dexamethasone-Based Regimens

Sung Won Lim, MD, Song Ee Park, Jangho Cho, Youjin Kim, Hansang Lee, Juhyun Hong, Eunseok Jeon, Jinoh Choi, Gayeon Lee, Byungjun Kim, Ju Hong Min, Jung Sun Kim, Jung Eun Lee, Joon Young Choi, Silvia Park, Seok Jin Kim, MD PhD, Jun Ho Jang, MD PhD, Won Seog Kim, MD, Ph. D., Chul Won Jung, Kihyun Kim, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3114.
https://doi.org/10.1182/blood.V130.Suppl_1.3114.3114
Published: 2017